Cynthia X. Ma, MD, Professor, Department of Medicine, Oncology Division of Medial Oncology of Washington University School of Medicine. In this audio, she speaks about the ASCO 2022 Abstract - FLEX, the 30,000 breast cancer transcriptome project: A platform for early breast cancer research using full-genome arrays paired with clinical data.
The FLEX Registry will be a large-scale population-based prospective registry. All patients with stage I to III breast cancer who have MammaPrint® and BluePrint testing on a primary breast tumor are eligible to participate in the FLEX Registry, which is designed to allow for additional study arms with minimal additional work and cost. The FLEX Registry will be designed to be adaptable, allowing for the insertion of additional focused substudies and arms after the initial research is completed.